Atanackovic, Djordje http://orcid.org/0000-0003-4747-488X
Avila, Stephanie V.
Lutfi, Forat
de Miguel-Perez, Diego http://orcid.org/0000-0002-2822-4466
Fan, Xiaoxuan
Sanchez-Petitto, Gabriela
Vander Mause, Erica http://orcid.org/0000-0003-3008-6186
Siglin, Jonathan
Baddley, John
Mannuel, Heather D.
Alkhaldi, Hanan
Hankey, Kim G. http://orcid.org/0000-0003-1699-6087
Lapidus, Rena
Kleinberg, Michael
Rabin, Joseph
Shanholtz, Carl
Rolfo, Christian
Rapoport, Aaron P.
Dahiya, Saurabh
Luetkens, Tim http://orcid.org/0000-0002-7085-9027
Article History
Received: 18 March 2021
Accepted: 2 November 2021
First Online: 16 December 2021
Competing interests
: C.R. was a speaker for Merck Sharp and Dohme, AstraZeneca, and Roche (CH) and has research collaborations (non-financial support) with Guardant Health; advisory board activity: Archer, Inivata and MD Serono, Novartis, and BMS. Research grant from LCRF-Pfizer. The rest of the authors declare no competing interests.